GLP-1 Microdosing, Brain Health, and Alzheimers Prevention: What the Evidence Actually Shows AI Overview GLP-1 medications such as semaglutide and tirzepatide are being studied for more than weight loss
One study found that patients who combined their weight-loss medication with a structured exercise routine were four times more likely to keep at least 10% of their weight off a year after stopping, compared to those who did not exercise
Penetration rates for treatment outside of the US tend to be much lower, especially in countries with poor healthcare systems
Obesity paradox in recurrent attacks of gout in observational studies: clarification and remedy
Reduced nausea is a common side effect of semaglutide
Despite many online success stories claiming it heals bones, joints, and stomach ulcers, there is no solid scientific evidence to back this up